Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.

New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

The study participants were real-life patients prescribed either semaglutide or liraglutide ... And people who drank alcohol reported drinking less on average after starting a GLP-1 drug.

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy and used to treat coexisting conditions.

These jabs, often prescribed under brand names like Saxenda (liraglutide) and Wegovy (semaglutide), work by suppressing appetite. The study, conducted by researchers in Ireland and Saudi Arabia ...

For the study, researchers followed 262 adults who were prescribed GLP-1 medications like semaglutide or liraglutide ... Notably, no participants reported drinking more after starting the medication.